Opportunity ID: 313456

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-19-209
Funding Opportunity Title: Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 04, 2019
Last Updated Date: Mar 04, 2019
Original Closing Date for Applications: May 06, 2021
Current Closing Date for Applications: May 06, 2021
Archive Date: Jun 11, 2021
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
County governments
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative on-demand, event -driven and long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy, and (HIV/STI) and non-HIV STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-209.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00248784 Apr 06, 2019 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259237 Apr 06, 2019 May 06, 2021 View

Package 1

Mandatory forms

313456 RR_SF424_2_0-2.0.pdf

313456 PHS398_CoverPageSupplement_4_0-4.0.pdf

313456 RR_OtherProjectInfo_1_4-1.4.pdf

313456 PerformanceSite_2_0-2.0.pdf

313456 RR_KeyPersonExpanded_2_0-2.0.pdf

313456 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

313456 RR_Budget_1_4-1.4.pdf

313456 RR_SubawardBudget30_1_4-1.4.pdf

313456 PHS398_ModularBudget_1_2-1.2.pdf

313456 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

313456 RR_SF424_2_0-2.0.pdf

313456 PHS398_CoverPageSupplement_5_0-5.0.pdf

313456 RR_OtherProjectInfo_1_4-1.4.pdf

313456 PerformanceSite_2_0-2.0.pdf

313456 RR_KeyPersonExpanded_2_0-2.0.pdf

313456 PHS398_ResearchPlan_4_0-4.0.pdf

313456 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

313456 RR_Budget_1_4-1.4.pdf

313456 RR_SubawardBudget30_1_4-1.4.pdf

313456 PHS398_ModularBudget_1_2-1.2.pdf

313456 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T12:33:08-05:00

Share This Post, Choose Your Platform!

About the Author: